About Mozart Therapeutics
Mozart Therapeutics is a company based in Seattle (United States) founded in 2020.. Mozart Therapeutics has raised $80 million across 2 funding rounds from investors including AbbVie, Lilly and Pfizer. The company has 14 employees as of December 31, 2021. Mozart Therapeutics offers products and services including MTX-101 and MTX-201. Mozart Therapeutics operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter Seattle, United States
- Employees 14 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Mozart Therapeutics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$80 M (USD)
in 2 rounds
-
Latest Funding Round
$25 M (USD), Series A
Jun 07, 2023
-
Investors
AbbVie
& 11 more
-
Employee Count
14
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mozart Therapeutics
Mozart Therapeutics offers a comprehensive portfolio of products and services, including MTX-101 and MTX-201. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Modulates CD8 Treg cells to restore immune balance in autoimmune diseases.
Targets CD8 Treg dysfunction for treating inflammatory disorders.
Unlock access to complete
Unlock access to complete
Funding Insights of Mozart Therapeutics
Mozart Therapeutics has successfully raised a total of $80M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $25.0M
-
First Round
First Round
(26 Oct 2021)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series A - Mozart Therapeutics | Valuation |
investors |
|
| Oct, 2021 | Amount | Series A - Mozart Therapeutics | Valuation | Arch Venture Partners , Sofinnova Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mozart Therapeutics
Mozart Therapeutics has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, Lilly and Pfizer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mozart Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mozart Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mozart Therapeutics Comparisons
Competitors of Mozart Therapeutics
Mozart Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mozart Therapeutics
Frequently Asked Questions about Mozart Therapeutics
When was Mozart Therapeutics founded?
Mozart Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Mozart Therapeutics located?
Mozart Therapeutics is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Mozart Therapeutics?
Katie Fanning is the current CEO of Mozart Therapeutics.
Is Mozart Therapeutics a funded company?
Mozart Therapeutics is a funded company, having raised a total of $80M across 2 funding rounds to date. The company's 1st funding round was a Series A of $55M, raised on Oct 26, 2021.
How many employees does Mozart Therapeutics have?
As of Dec 31, 2021, the latest employee count at Mozart Therapeutics is 14.
What does Mozart Therapeutics do?
Mozart Therapeutics was founded in 2020 and is based in Seattle, United States. Biologics targeting a network of pathogenic CD4 and cytolytic-regulatory CD8 T cells are developed for treating immunological disorders. The focus is placed on immune modulators within the biotechnology sector to address autoimmune and inflammatory conditions through therapeutic solutions.
Who are the top competitors of Mozart Therapeutics?
Mozart Therapeutics's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
What products or services does Mozart Therapeutics offer?
Mozart Therapeutics offers MTX-101 and MTX-201.